From Adversity to Advancement The Critical Evolution of High-Risk Neuroblastoma Treatment and Research
The trajectory of pediatric oncology is often defined by the intersection of individual patient struggles...
Knowledge and News for the Global Fight Against Cancer.
The trajectory of pediatric oncology is often defined by the intersection of individual patient struggles...
CureSearch for Children’s Cancer, a national non-profit organization dedicated to ending childhood cancer by driving...
The global scientific community is profoundly saddened by the passing of Dr. Susumu Tonegawa, a...
Biohaven Pharmaceuticals, a company in its second iteration following a high-profile acquisition and subsequent spin-off,...
The case of Lily, a two-year-old child currently undergoing her second intensive battle with neuroblastoma,...
The landscape of pediatric oncology is undergoing a fundamental transformation as the demand for research...
The trajectory of a family’s life can be irrevocably altered in a single evening, a...
In a pivotal move to safeguard the future of cancer research, the Cancer Research Institute...
The biopharmaceutical landscape witnessed a significant tremor on Wednesday, August 26, 2026, as Spyre Therapeutics,...
The Path to Diagnosis: From Routine Checkup to Emergency Care In the field of pediatric...